Latest Platform Growth News

Page 3 of 6
Rhythm Biosciences reports strong Q1 FY26 progress, securing strategic partnerships and advancing commercial readiness for its ColoSTAT® colorectal cancer test alongside robust growth in its geneType platform.
Ada Torres
Ada Torres
29 Oct 2025
MA Financial Group has reported a surge in assets under management and loan book growth alongside a major $525 million property acquisition, signaling robust momentum across its financial services divisions.
Claire Turing
Claire Turing
23 Oct 2025
Praemium reported a robust start to FY2026 with total Funds Under Administration rising 13% to $67 billion, led by strong organic growth in its Spectrum platform. The company’s strategic focus on high-net-worth clients and platform consolidation continues to gain traction.
Claire Turing
Claire Turing
21 Oct 2025
HUB24 has reported a record $5.2 billion in net inflows for Q1 FY26, boosting its Funds Under Administration to $146.5 billion and securing the top spot for adviser satisfaction in Australia.
Claire Turing
Claire Turing
21 Oct 2025
Aspermont Limited has completed its Share Purchase Plan and shortfall placement, raising over A$1 million to fund its digital transformation and AI-driven services expansion.
Victor Sage
Victor Sage
17 Oct 2025
Hiremii Group has successfully raised $650,000 through an oversubscribed placement, underscoring strong investor confidence as it pushes forward with commercialising its AI-driven recruitment platform.
Sophie Babbage
Sophie Babbage
10 Oct 2025
SiteMinder's 2025 Investor Day presentation highlights its Smart Platform's progress, AI-driven hotel revenue tools, and reiterates a strong FY26 outlook with ambitions for accelerated growth.
Sophie Babbage
Sophie Babbage
23 Sept 2025
Aspermont Limited has raised an additional $891,210 through its Share Purchase Plan, complementing a recent $1.75 million institutional placement. This capital injection supports the company’s strategic pivot towards data-driven mining intelligence and AI-powered services.
Maxwell Dee
Maxwell Dee
17 Sept 2025
Osteopore Limited has established OsteoRx, a new special purpose vehicle, with an initial AUD 0.5 million investment to accelerate breakthroughs in cellular regenerative medicine. This strategic move integrates a controlling stake in US-based RxCell Inc, expanding Osteopore’s footprint in the fast-growing stem cell market.
Ada Torres
Ada Torres
1 Sept 2025
Butn Limited has reported record revenue growth and its first positive operating cash flow for FY25, alongside securing a substantial $100 million funding facility to fuel future expansion.
Claire Turing
Claire Turing
25 Aug 2025
Vitura Health Limited has announced its third fully franked dividend of 0.2 cents per share following a profitable FY2025, reinforcing its unique position in the medicinal cannabis sector. Shareholders are invited to participate in a discounted Dividend Reinvestment Plan.
Ada Torres
Ada Torres
25 Aug 2025
Vitura Health reported a modest revenue increase to $124 million for FY2025, while net profit dipped 5.35% due to margin pressures and investment in new platforms. The company declared a fully franked dividend and highlighted growth in telehealth and medical services.
Ada Torres
Ada Torres
25 Aug 2025